Free Trial

Guardian Pharmacy Services (NYSE:GRDN) Hits New 12-Month High - What's Next?

Guardian Pharmacy Services logo with Medical background

Key Points

  • Guardian Pharmacy Services shares reached a new 52-week high of $28.98, closing last at $28.72 with a trading volume of 392,473 shares.
  • Analyst ratings for Guardian Pharmacy Services have improved, with Wall Street Zen upgrading the stock to a "strong-buy", while Truist Financial raised its price target from $25.00 to $28.00.
  • Institutional investors have shown interest in Guardian Pharmacy Services, with several acquiring new positions and notable increases in holdings, such as a 76.8% increase by the Police & Firemen's Retirement System of New Jersey.
  • Five stocks to consider instead of Guardian Pharmacy Services.

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $28.98 and last traded at $28.72, with a volume of 392473 shares. The stock had previously closed at $28.21.

Wall Street Analyst Weigh In

A number of brokerages have commented on GRDN. Wall Street Zen upgraded shares of Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a report on Sunday, August 17th. Truist Financial restated a "buy" rating and issued a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, Guardian Pharmacy Services currently has an average rating of "Buy" and an average price target of $25.67.

View Our Latest Report on Guardian Pharmacy Services

Guardian Pharmacy Services Stock Down 2.2%

The stock has a market cap of $1.88 billion and a price-to-earnings ratio of -19.49. The firm's 50 day moving average is $23.42 and its two-hundred day moving average is $22.40.

Institutional Investors Weigh In On Guardian Pharmacy Services

Several institutional investors and hedge funds have recently bought and sold shares of the business. TimesSquare Capital Management LLC bought a new position in Guardian Pharmacy Services in the 2nd quarter worth about $17,351,000. Franklin Resources Inc. grew its position in Guardian Pharmacy Services by 32.2% in the 2nd quarter. Franklin Resources Inc. now owns 976,207 shares of the company's stock worth $20,803,000 after purchasing an additional 237,630 shares during the last quarter. Boston Partners bought a new position in Guardian Pharmacy Services in the 2nd quarter worth about $4,227,000. Geode Capital Management LLC grew its position in Guardian Pharmacy Services by 65.9% in the 2nd quarter. Geode Capital Management LLC now owns 336,701 shares of the company's stock worth $7,177,000 after purchasing an additional 133,715 shares during the last quarter. Finally, Sei Investments Co. grew its position in Guardian Pharmacy Services by 227.2% in the 2nd quarter. Sei Investments Co. now owns 181,481 shares of the company's stock worth $3,867,000 after purchasing an additional 126,008 shares during the last quarter.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Further Reading

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.